nach oben

Erschienen in:

01.11.2022 | Clinical study

Dedicated system for COVID-19 vaccine safety surveillance at Lareb

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

A dedicated system for COVID-19 vaccine safety surveillance at the Netherlands Pharmacovigilance Centre Lareb, with a fully automated process for dealing with high volumes of individual case safety reports (ICSRs) during mass COVID-19 vaccination campaigns, has enabled reports to be processed within the compliance timeframe for the European Medicines Agency's Eudravigilance system, and signal detection, say authors of an article published in Drug Safety. …

Oosterhuis I, et al. Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience Drug Safety : 16 Nov 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01253-5

Titel: Dedicated system for COVID-19 vaccine safety surveillance at Lareb
Publikationsdatum: 01.11.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-28388-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Dedicated system for COVID-19 vaccine safety surveillance at Lareb

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Capecitabine/temozolomide

Multiple drugs

Methylprednisolone

Elasomeran

Adalimumab/infliximab

Multiple drugs